CD1-restricted T-cell responses and microbial infection

Nature

Volumn 406, Issue 6797, 2000, Pages 788-792

  Park, Se Ho ^a   Bendelac, Albert ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; BACTERIAL INFECTION; CELLULAR IMMUNITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; HUMANS; INFECTION; KILLER CELLS, NATURAL; LIPIDS; T-LYMPHOCYTES; VACCINES;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0034680109     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35021233     Document Type: Review

References (48)

1. Calabi, F., Jarvis, J. M., Martin, L. H. & Milstein, C. Two classes of CD1 genes. Eur. J. Immunol. 19, 285-292 (1989).
2. Porcelli, S. A. & Modlin, R. L.The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329 (1999).
3. Beckman, E. M. et al. Recognition of a lipid antigen by CD1-restricted αβ T cells. Nature 372, 691-694 (1994).
4. Moody, D. B. et al. Structural requirements for glycolipid antigen recognition by CPIb-restricted T cells. Science 278, 283-286 (1997).
5. Sieling, P. A. et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
6. Moody, D. B. et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888 (2000).
7. Lee, R. E., Brennan, P. J. & Besra, G. S. Mycobacterium tuberculosis cell envelope. Curr. Top. Microbiol. Immunol. 215, 1-27 (1996).
8. Natori, T., Morita, M., Akimoto, K. & Koezuka, Y. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the sponge Agelas mauritianus. Tetrahedron 50, 2771-2784 (1994).
9. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of vα1 4 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
10. Shamshiev, A. et al. Self glycolipids as T-cell autoantigens. Eur J. Immunol. 29, 1667-1675 (1999).
11. Castano, A. R. et al. Peptide binding and presentation by mouse CD1. Science 269, 223-226 (1995).
12. Zeng, Z. H. et al. The crystal structure of murine CD1: an MHC-like told with a large hydrophobic antigen binding groove. Science 277, 339-345 (1997).
13. Porcelli, S. A. & Brenner, M. B. Antigen presentation: mixing oil and water. Curr. Biol. 7, R508-R511 (1997).
14. Naidenko, O. V. et al. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190, 1069-1080 (1999).
15. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
16. Joyce, S. et al. Natural ligand of mouse CD1d1: cellular glycosylphosphalidylinositol. Science 279, 1541-1544 (1998).
17. Ernst, W. A. et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 8, 331-340 (1998).
18. Burdin, N. et al. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates V α 14 NK T lymphocytes. J. Immunol. 161, 3271-3281 (1998).
19. Sugita, M. et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 11, 743-752 (1999).
20. Schaible, U. E., Hagens, K., Fischer, K., Collins, H. I., & Kaufmann, S. H. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J. Immunol. 164, 4843-4852 (2000).
21. Jackman, R. M. et al. The tyrosine-containing cytoplasmic tail of CD1b inessential for its efficient presentation of bacterial lipid antigens. Immunity 8, 341-351 (1998).
22. Chiu, Y. H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
23. Briken, V., Jackman, R. M., Watts, G. F. M., Rogers, R. A. & Porcelli, S. A. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J. Exp. Med. 192, 281-288 (2000)
24. Siding, P. A. et al. Evidence for human CD4 T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J. Immunol. 164, 4790-4796 (2000).
25. Bendelac, A., Rivera, M. N., Park, S.-H. & Roark, J. H. Mouse CD1-specific NKI T cells. Development, specificity, and function. Annu. Rev. Immunol. 15, 535-562 (1997).
26. Stenger, S. et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687 (1997).
27. Tatu, C., Ye, J., Arnold, L. W. & Clarke, S. H. Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J. Exp. Med. 190, 903-914 (1999).
28. Benedict, C. L. & Kearney, J. F. Increased functional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 10, 607-617 (1999).
29. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. Natural killer cells in antviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999).
30. Bendelac, A. et al. CD1 recognition by mouse NK1 T lymphocytes. Science 268, 863-865 (1995).
31. Spada, F. M. et al. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191, 937-948 (2000).
32. Park, S. H., Benlagha, K., Lee, D., Balish, E. & Bendelac, A. Unaltered phenotype, tissue distribution and function of Vα14(+) NKT cells in germ-free mice. Eur. J. Immunol. 30, 620-625 (2000).
33. Schofield, L. et al. CD1d-restricted immunoglobulin G formation to GP1-anchored antigens mediated by NKT cells. Science 283, 225-229 (1999).
34. Molano, A. et al. Cutting edge. The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role cell glycosylphosphatidylinositols in NKT cell activation and anti-malarial responses. J. Immunol. 164, 5005-5009 (2000).
35. Gumperz, J. E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
36. Burdin, N., Brossay, L. & Kronenberg, M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29, 2014-2025 (1999).
37. Carnaud, C. et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650 (1999).
38. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128 (1999).
39. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med, 187, 1047-1056 (1998).
40. Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
41. Wilson, S. R. et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature 391, 177-181 (1998).
42. Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661-668 (2000).
43. Cui, J. et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-attivated Vα14 natural killer T cells. J. Exp. Med. 190, 783-792 (1999).
44. Singh, N. et al. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163, 2373-2377 (1999).
45. Shinkai, K. & Locksley, R. M. CD1, tuberculosis, and the evolution of major histocompatibility complex molecules. J. Exp. Med. 191, 907-914 (2000).
46. Beldjord, K., Beldjord, C., Macintyre, E., Even, P. & Sigaux, F. Peripheral selection of V δ I + cells with restricted T cell receptor delta gene junctional repertoire in the peripheral blood of healthy donors. J. Exp. Med. 178, 121-127 (1993).
47. Besra, G. & Chatterjee, D. in Tuberculosis: Pathogenesis, Protection and Control. (ed. Bloom. B.) 285-306 (American Society for Microbiology, Washington, DC, 1994).
48. Almeida, I. C. et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19, 1476-1485 (2000).